Login / Signup

Diterpenoid DGT alleviates atopic dermatitis-like responses in vitro and in vivo via targeting IL-4Rα.

Jingjing GaoDong LiZhangyang FengXiaoqiang ZhuFei YangBiyan ZhangMingming HuYanping WangHaimei FengYunhui YuQing XieZijun ChenYunsen Li
Published in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (2024)
DGT's potent anti-inflammatory effects and good safety profile suggest that it is a potential candidate for the treatment of atopic dermatitis.
Keyphrases
  • atopic dermatitis
  • cancer therapy
  • mouse model
  • human health
  • risk assessment
  • smoking cessation